• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Alembic`s Generic Doxercalciferol Receives Approval in the U.S.

    15 Jun 2023 //

    FDA

    Eugia Pharma`s Generic Doxercalciferol Receives Approval in the U.S.

    24 Jan 2022 //

    FDA

    Dr. Reddy`s Laboratories announces launch of Doxercalciferol Injection in U.S

    22 Nov 2019 //

    BIO SPACE

    Gland Pharma`s Generic Doxercalciferol Receives Approval in US

    30 Sep 2019 //

    FDA

    Lupin receives FDA green light for generic Hectorol

    06 Nov 2018 //

    DRUG STORE NEWS

    Lupin`s Generic Doxercalciferol Receives Approval in US

    06 Nov 2018 //

    FDA

    Enforcement Report - Week of April 19, 2017

    19 Apr 2017 //

    FDA

    Rising Pharms Generic Doxercalciferol Approved In US

    12 Sep 2016 //

    FDA

    Akorn`s Generic Doxercalciferol Approved in US For Hyperparathyroidism and Bone Disease

    12 May 2015 //

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.